Coccidioidomycosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 37: Line 37:


==Microscopic pathology==
==Microscopic pathology==
It is a dimorphic fungi and exists as
It is a dimorphic fungi and on microscopy the following can be seen
*Spherule with endospores in humans
*Spherule with endospores  
*Rarely as hyphae ( some cases are positive for hyphae in lungs)
*Rarely as hyphae in lung biopsy
[[Image:Microscopy valley fever.jpg|center|Histopathological changes in coccidioidomycosis]]
[[Image:Microscopy valley fever.jpg|center|Histopathological changes in coccidioidomycosis]]



Revision as of 00:07, 21 March 2017

Coccidioidomycosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Coccidioides immitis
Coccidioides posadasii

Differentiating Coccidioidomycosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Coccidioidomycosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Coccidioidomycosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coccidioidomycosis pathophysiology

CDC on Coccidioidomycosis pathophysiology

Coccidioidomycosis pathophysiology in the news

Blogs on Coccidioidomycosis pathophysiology

Directions to Hospitals Treating Coccidioidomycosis

Risk calculators and risk factors for Coccidioidomycosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Vidit Bhargava, M.B.B.S [2]; Aditya Ganti M.B.B.S. [3]

Overview

Coccidioidomycosis is a fungal infection, that is acquired through inhalation of the spores that is present in the environment. Following transmission, coccidioidomycosis are deposited into terminal bronchioles and enlarge, become rounded and develop internal septations to form what are known as the spherules. It then disseminates to the lymphatics and blood stream to gain access to any organ of the body.[1][2][3][4]

Pathogenesis

The pathogenesis of coccidioidomycosis can be described in following steps.[1][2][3][4]

Transmission

  • Coccidioiodomycosis exist as mycelia in the soil with septations.
  • During hot climate or dry environment, they proliferate asexually, transforming into spores, known as arthroconidia.
  • Infection is caused by inhalation of these arthroconidia.
  • The disease is not transmitted from person to person.

Incubation period

  • Incubation period of coccidioidomycosis varies from one to three weeks.

Dissemination

  • Following inhalation, arthroconidia reach terminal bronchioles.
  • Then they are ingested by pulmonary macrophages.
  • Inside macrophages these arthroconidia enlarge, become rounded and develop internal septations to form what are known as the spherules.
  • It then disseminates to the lymphatics and blood stream to gain access to any organ of the body.

Seeding

  • Spherules contain uni-nuclear cells called as endospores which may propagate the infection further as they have the capability to develop into spherules.
  • This conversion of anthroconidia into spherules initiates an inflammatory reaction and leads to a chemotaxic response (peptides derived from activation of the complement pathway, leukotrienes ) which attracts neutrophils and eosinophils to the site of inflammation.
  • Cell mediated immunity keeps the infection in check and keeps them limited to the organ of origin by forming granulomas.

Immune response

Coccidioidomycosis elicits cell-mediated immune responses.

  • Delayed type hypersensitivity to coccidioidal antigens is common after acute infection has resolved.
  • Dissemination usually occurs via the lymphatics and is more common in immune suppressed in whom the primary infection is not contained.


Life cycle of coccidiodes
Life cycle of coccidiodes
Life cycle and epidemiology
Life cycle and epidemiology

Genetics

There is no known genetic association to coccidioidomycosis.

Microscopic pathology

It is a dimorphic fungi and on microscopy the following can be seen

  • Spherule with endospores
  • Rarely as hyphae in lung biopsy
Histopathological changes in coccidioidomycosis
Histopathological changes in coccidioidomycosis

Microscopic Pathology

{{#ev:youtube|RtpvzCfFwfg}}

References

  1. 1.0 1.1 Stockamp NW, Thompson GR (2016). "Coccidioidomycosis". Infect. Dis. Clin. North Am. 30 (1): 229–46. doi:10.1016/j.idc.2015.10.008. PMID 26739609.
  2. 2.0 2.1 Twarog M, Thompson GR (2015). "Coccidioidomycosis: Recent Updates". Semin Respir Crit Care Med. 36 (5): 746–55. doi:10.1055/s-0035-1562900. PMID 26398540.
  3. 3.0 3.1 DiCaudo DJ (2014). "Coccidioidomycosis". Semin Cutan Med Surg. 33 (3): 140–5. PMID 25577855.
  4. 4.0 4.1 Malo J, Luraschi-Monjagatta C, Wolk DM, Thompson R, Hage CA, Knox KS (2014). "Update on the diagnosis of pulmonary coccidioidomycosis". Ann Am Thorac Soc. 11 (2): 243–53. doi:10.1513/AnnalsATS.201308-286FR. PMID 24575994.

Template:WH Template:WS